Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Announcing CT Foundation, a new medical imaging embedding tool that accepts a computed tomography (CT) volume as input and returns a small, information-rich numerical embedding that can be used to rapidly train models. Learn more and try it out yourself →

246,327 görüntüleme • 1 yıl önce •via X (Twitter)

10 Yorum

Rand profil fotoğrafı
Rand1 yıl önce

Proud of @Google today

Braydon Dymm, MD profil fotoğrafı
Braydon Dymm, MD1 yıl önce

Great! Next up, MRI Foundation?

BensenHsu profil fotoğrafı
BensenHsu1 yıl önce

The researchers aim to expand the capabilities of Gemini, a powerful multimodal model, to handle medical tasks. They create a new family of models called Med-Gemini that can process diverse medical data like images, genomics, and text. Med-Gemini-2D sets a new standard for chest X-ray report generation, with 57% and 96% of AI reports on normal and abnormal cases evaluated as "equivalent or better" than original radiologist reports. Med-Gemini-2D also outperforms previous models on visual question answering and image classification tasks. Med-Gemini-Polygenic outperforms the standard linear approach for disease risk prediction and generalizes to new diseases. full paper:

Nasim AL Fahad profil fotoğrafı
Nasim AL Fahad1 yıl önce

This sounds like a game-changer for medical imaging! CT Foundation seems like a powerful tool that can really speed up model training.

Alex Fridd profil fotoğrafı
Alex Fridd1 yıl önce

This could drastically reduce the time and data needed to develop new diagnostic tools.

Uri Gil profil fotoğrafı
Uri Gil1 yıl önce

yes! more of this and less silly podcast generators

Florian Camiade 🗝️ profil fotoğrafı
Florian Camiade 🗝️1 yıl önce

This is exactly the kind of progress we need!

Laurence Bremner profil fotoğrafı
Laurence Bremner1 yıl önce

What does the embedding itself point to, can it be used on its own?

Steven Ratnik profil fotoğrafı
Steven Ratnik1 yıl önce

@sundarpichai It's amazing

neto profil fotoğrafı
neto1 yıl önce

In the 70's the scientific community believed we would be able to transcribe dreams. Good work, by the way!

Benzer Videolar

PHOTON COUNTING CT is NOT a better CT It is a NEW imaging modality Photon Counting CT (PCCT) represents a transformative leap in medical imaging, not only as a molecular imaging modality but also as a technology offering ultra-high resolution and functional imaging capabilities. It is fundamentally more than just an enhanced version of traditional CT—PCCT introduces new ways of seeing and understanding the human body, providing critical insights at the molecular, structural, and functional levels. This positions PCCT as a unique imaging modality that requires a fresh approach to technical implementation, operational workflows, and financial planning. Despite the larger upfront investment, PCCT’s ability to drastically reduce downstream healthcare costs makes it a highly valuable investment in the long run. 1. Technical Innovations • Molecular Imaging and Energy Discrimination: Unlike traditional CT, which simply measures the total absorbed energy, PCCT counts individual X-ray photons and differentiates their energy levels. This allows for precise molecular imaging, revealing the composition of tissues and materials at a biochemical level. By distinguishing between different tissue types and contrast agents, PCCT opens up new diagnostic possibilities, such as identifying molecular biomarkers in tumors or distinguishing between stable and unstable plaque in coronary arteries. This capability shifts the focus of imaging from purely anatomical to both anatomical and molecular, offering more comprehensive diagnostic information. • Ultra-High Spatial Resolution: PCCT features significantly smaller detector elements compared to conventional CT scanners, allowing for ultra-high resolution imaging. This means clinicians can visualize fine structures such as microcalcifications in arteries, small lesions in soft tissues, or the intricate architecture of bones. This level of detail was previously unattainable with traditional CT. When combined with molecular imaging, this ultra-high resolution allows for the precise localization and characterization of disease at very early stages, which is essential for early diagnosis and intervention. • Functional Imaging Capabilities: PCCT also excels as a functional imaging modality. By capturing energy-resolved information, PCCT can provide insights into tissue functionality and dynamic physiological processes. For instance, it can detect changes in blood flow, tissue perfusion, and oxygenation without the need for additional contrast agents or scans. This functionality allows for real-time assessment of physiological processes, making it particularly valuable in cardiology, oncology, and neurology for evaluating organ function and monitoring disease progression. • Reduced Noise and Artifact Reduction: Photon-counting technology dramatically reduces electronic noise and imaging artifacts, such as beam hardening, resulting in clearer and more accurate images. The ability to deliver ultra-high resolution images with minimal artifacts improves diagnostic accuracy, reducing the need for repeat scans and ensuring that even subtle abnormalities are detected. 2. Operational Considerations • New Workflow for Molecular, High-Resolution, and Functional Imaging: The integration of molecular, ultra-high resolution, and functional imaging into routine clinical workflows introduces complexity that requires adaptation. Radiologists and technicians need specialized training to interpret and analyze multi-energy datasets that include molecular and functional information. PCCT produces a vast amount of detailed data, requiring clinicians to adopt new imaging protocols and refine their diagnostic approaches to fully leverage its capabilities. • Post-Processing and Data Management: PCCT generates richer, more complex datasets, which necessitates advanced post-processing tools and data management systems. Existing PACS and imaging software may not be equipped to handle such large volumes of data or to process functional and molecular information effectively. This means healthcare institutions must invest in robust IT infrastructure, including upgraded software and storage solutions, as well as provide additional training for staff on new imaging analysis techniques. • Revised Clinical Protocols: The molecular, functional, and ultra-high resolution imaging capabilities of PCCT will likely prompt changes in clinical protocols. For instance, the need for contrast agents may be reduced, simplifying patient preparation and decreasing the risk of adverse reactions. Additionally, the ability to monitor physiological functions in real-time through functional imaging could lead to more dynamic diagnostic procedures, such as assessing the effectiveness of interventions or treatments in real-time. 3. Financial Impact • Higher Initial Investment: PCCT systems are more expensive than traditional CT scanners due to their advanced technology, which includes photon-counting detectors and the computational power required for high-resolution, molecular, and functional imaging. While this upfront cost is significant, it is crucial to view it in the broader context of the downstream benefits and cost reductions that PCCT offers. • Downstream Cost Reductions: Although the initial capital investment is higher, PCCT’s ability to combine molecular, functional, and ultra-high resolution imaging leads to substantial reductions in downstream healthcare costs. Its superior diagnostic accuracy minimizes the need for follow-up tests, repeat scans, or invasive diagnostic procedures, such as diagnostic coronary angiographies. For example, in cardiology, PCCT can precisely differentiate between types of coronary plaque, reducing the need for invasive procedures to assess risk. • Lower Overall Healthcare Expenditures: By enabling earlier, more accurate diagnoses, PCCT can reduce the overall cost of patient care. Early detection of disease, particularly through its molecular and functional imaging capabilities, allows for more targeted treatments, potentially preventing the need for more aggressive and expensive interventions down the line. For instance, early-stage tumor detection via molecular imaging could lead to less invasive treatments, reducing hospital stays and improving patient outcomes, ultimately driving down healthcare costs. • Increased ROI Through Enhanced Patient Outcomes: Over time, the combination of molecular, functional, and ultra-high resolution imaging enhances diagnostic precision, which translates into better patient outcomes. Improved diagnostic accuracy reduces the incidence of unnecessary procedures, minimizes treatment delays, and results in more personalized and effective care. This leads to increased patient satisfaction, better healthcare outcomes, and greater patient throughput—all factors that improve the institution’s return on investment (ROI). • Competitive Advantage and New Revenue Streams: By adopting PCCT, healthcare institutions position themselves at the forefront of advanced imaging technologies. The ability to offer molecular, functional, and ultra-high resolution imaging creates a competitive advantage, attracting more complex and high-value cases. This can boost the institution’s reputation for excellence in diagnostics, leading to increased referrals, new patient populations, and expanded revenue opportunities. Summary Photon Counting CT (PCCT) is not just an evolution of existing CT technology—it is a molecular, ultra-high resolution, and functional imaging modality that fundamentally transforms the diagnostic landscape. Its ability to capture detailed molecular data, visualize minute anatomical structures with ultra-high resolution, and provide real-time functional imaging opens new possibilities for earlier and more precise diagnoses. While the financial investment in PCCT is larger, the reduction in downstream healthcare costs through improved diagnostic accuracy, fewer unnecessary interventions, and earlier disease detection far outweighs the initial expense. For institutions committed to advancing patient care and improving long-term financial outcomes, PCCT is an essential investment in the future of medical imaging. The video attached shows a patient accessing the Hospital for ACS. PCCT can provide ALL the imaging information of the concurrent imaging modalities (CXR, CAG, Echo, CMR) that you see around it... that's a lot! #PhotonCountingCT #MolecularImaging #UltraHighResolution #FunctionalImaging #FutureOfImaging #AdvancedMedicalImaging #EarlyDiseaseDetection #InnovativeCT #CuttingEdgeHealthcare #PrecisionDiagnostics #HealthcareInnovation #MedicalTechnology #CostEffectiveImaging #NextGenCT #PatientCareRevolution

Dr. Filippo Cademartiri

11,820 görüntüleme • 1 yıl önce

Dear Global Pioneers,❤️ I've just posted a new video. Since many pioneers don't understand English, I will explain its content. I appreciate the concern for my health and my eyes. My eyes used to have high pressure, causing them to be very painful and teary. I haven't had time to see a doctor yet. However, I've reduced the time spent answering questions in groups and have dedicated more time to yoga and working out, which has significantly improved my eyes. As we approach June, everyone is eager to know if CT can OM on Pi2Day. I believe they won't announce before the date, as Pi Network OM is a significant historical event and a revolution, making it confidential information. It's important that all pioneers work diligently to collaborate with CT to ensure that the conditions are met. 1. Complete your checklist and help your team with tasks such as KYC, migration, and liveness check. 2. Help protect Pi Network's security by reporting instances of black market account selling and buying. Provide usernames, public information, and proof to CT to freeze these accounts. Many have already been frozen, and increased supervision of policy violations will aid the OM. 3. Generate more GCV data through small transactions. Even a single transaction will greatly benefit GCV and OM. 4. The purpose of filing a petition is to make CT aware of how many pioneers are prepared for Pi2Day and the efforts made, as well as the security of the current blockchain. I can see that CT has heard our voice and is doing their job. If there are concerns about the pace to OM, it's important to use our judgement to understand why. I believe that if you are astute, you would understand the reasoning. We trust and collaborate with CT to safeguard our network and submit a petition to ensure they have enough information to make the best arrangement for the OM. We pioneers believe that June 28th is the perfect timing. Doris Yin 🪷🪷🪷

Doris Yin 东方紫莲🪷

24,644 görüntüleme • 2 yıl önce